Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00945763 · ClinicalTrials.gov registry record · Phase 2
Single Dose Study of N1539 in the Treatment of Pain Secondary to Dental Impaction Surgery
A Phase 2 study, sponsored by Alkermes.
- Completed
- Registry status
- Phase 2
- Development phase
- 230
- Enrollment target
NCT00945763: Completed Phase 2 study, sponsored by Alkermes.
NCT00945763 is a Phase 2 study that has completed, run by Alkermes. The registered enrollment target is 230 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (73% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00945763, a Phase 2 study, has completed, sponsored by Alkermes.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 230 participants
- Enrollment target
Study Summary
To evaluate the safety and efficacy of single IV doses of N1539 after dental impaction surgery.
Interventions
- DRUG placebo
- DRUG N1539
- DRUG Motrin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 230 participants |
| Start Date | 2009-07 |
| Est. Completion | 2009-11 |
| Phase | Phase 2 |
What the finished NCT00945763 record still lists
NCT00945763 is an interventional study that assigns participants to a tested intervention. The registered 230 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (73% higher).
The record links to 0 conditions, and to 3 interventions - of which placebo is the first listed.
NCT00945763 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00945763 about?
NCT00945763 is a clinical study titled "Single Dose Study of N1539 in the Treatment of Pain Secondary to Dental Impaction Surgery". To evaluate the safety and efficacy of single IV doses of N1539 after dental impaction surgery.
What is the current status of trial NCT00945763?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 230 participants. The study started on 2009-07. Estimated completion is 2009-11.
What interventions are being tested in trial NCT00945763?
The interventions under investigation include: placebo (DRUG), N1539 (DRUG), Motrin (DRUG).
Who is sponsoring clinical trial NCT00945763?
This trial is sponsored by Alkermes, which has 66 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00945763's enrollment target sits among peer trials
230 257th of 2000 higher than 1,737 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02710253 · 230 participants · Phase 2
Salvage Radiation Therapy in Treating Patients With Metastatic Cancer That Has Progressed After Systemic Immunotherapy
- NCT02777879 · 230 participants
Lung Microbiome and Inflammation in Early COPD
- NCT03824483 · 230 participants · Phase 2
Study of Zanubrutinib, Obinutuzumab, and Venetoclax in Patients With Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL)
- NCT03833622 · 230 participants · NA
Shared Decision Making to Improve Goals of Care in the ED
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia